Dupixent (Dupilumab)

**Product type:** Human Prescription Drug

**Active ingredient:** DUPILUMAB

**Strength:** 200 mg/1.14mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** sanofi-aventis U.S. LLC

**Marketing category:** BLA (BLA761055)

**Pharmacologic class:** Antibodies, Monoclonal [CS], Interleukin 4 Receptor alpha Antagonists [MoA], Interleukin-4 Receptor alpha Antagonist [EPC]